Chapter 3. Recent Advances in the Design and Characterization of Muscarinic Agonists and Antagonists
- 1 January 1994
- book chapter
- Published by Elsevier
Abstract
No abstract availableThis publication has 75 references indexed in Scilit:
- Immunological localization of m1–m5 muscarinic acetylcholine receptors in peripheral tissues and brainPublished by Elsevier ,2002
- New functionally selective muscarinic agonistsLife Sciences, 1993
- Characterization of muscarinic agonists in recombinant cell linesLife Sciences, 1993
- Synthesis and structure-activity studies of a series of spirooxazolidine-2,4-diones: 4-oxa-analogs of the muscarinic agonist 2-ethyl-8-methyl-2,8-diazaspiro[4.5]decane-1,3-dioneJournal of Medicinal Chemistry, 1993
- Therapeutic potential of CNS-active M2 antagonists: Novel structures and pharmacologyLife Sciences, 1993
- The design of novel muscarinic partial agonists that have functional selectivity in pharmacological preparations in vitro and reduced side-effect profile in vivoLife Sciences, 1993
- WAL 2014 - A muscarinic agonist with preferential neuron-stimulating propertiesLife Sciences, 1993
- Pharmacological characterization of a novel muscarinic partial agonist, YM796, in transfected cells expressing the m1 or m2 muscarinic receptor geneLife Sciences, 1992
- Urea and 2-imidazolidone derivatives of the muscarinic agents oxotremorine and N-methyl-N-(1-methyl-4-pyrrolidino-2-butynyl)acetamideJournal of Medicinal Chemistry, 1992
- Cholinergic activity of acetylenic imidazoles and related compoundsJournal of Medicinal Chemistry, 1991